cutan
leishmaniasi
neglect
tropic
diseas
caus
parasit
leishmania
transmit
sandfli
becom
major
health
problem
mani
tropic
subtrop
countri
especi
region
conflict
polit
instabl
current
limit
drug
treatment
avail
licens
vaccin
thu
need
therapeut
intervent
remain
urgent
previous
dna
vaccin
encod
kda
sandfli
phlebotomu
papatasi
salivari
protein
recombin
nonpathogen
leishmania
tarentola
secret
shown
induc
protect
immun
leishmania
major
mice
demonstr
promis
vaccin
candid
studi
develop
ferment
process
yeast
yield
scalabl
purif
process
consist
chromatograph
purif
step
high
bind
capac
suggest
produc
econom
biophysicalbiochem
analysi
purifi
indic
protein
high
puriti
conform
stabl
ph
importantli
recombin
protein
defin
structur
similar
relat
phlebotomu
duboscqi
impli
suitabl
yeast
express
system
produc
correctli
fold
abbrevi
use
cl
cutan
leishmaniasi
kda
sandfli
p
papatasi
salivari
protein
kda
sandfli
p
duboscqi
salivari
protein
od
optic
densiti
dissolv
oxygen
bh
bed
height
id
intern
diamet
cv
column
volum
leishmaniasi
neglect
tropic
diseas
caus
protozoan
parasit
genu
leishmania
transmit
human
phlebotomin
sandfli
approxim
million
new
case
year
annual
death
leishmaniasi
addit
infect
accru
million
disabilityadjust
life
year
annual
alarmingli
approxim
million
peopl
live
endem
area
risk
cutan
leishmaniasi
cl
common
manifest
highest
preval
report
afghanistan
iran
syria
algeria
brazil
colombia
highest
rate
cl
occur
area
polit
unrest
conflict
lesion
caus
cl
leav
sever
disfigur
scar
often
caus
social
stigmat
inde
emerg
evid
indic
million
peopl
may
affect
chronic
scar
cl
signific
percentag
suffer
comorbid
depress
psychiatr
sequela
therefor
current
global
burden
diseas
estim
like
fail
captur
full
rang
human
diseas
humanitarian
impact
obtain
blood
meal
sandfli
inject
salivari
protein
counteract
hemostasi
process
parasit
present
transmit
human
host
salivari
protein
immunogen
human
canid
mice
repeat
exposur
sandfli
salivari
gland
homogen
sandfli
bite
shown
caus
delayedtyp
hypersensit
salivari
compon
shown
imped
abil
parasit
infect
host
yield
protect
infect
similar
protect
effect
insect
salivari
protein
also
seen
vectorborn
diseas
exampl
anim
preexpos
tick
bite
protect
borrelia
infect
mice
preexpos
mosquito
bite
protect
malaria
addit
anim
vaccin
respect
vector
salivari
protein
also
shown
protect
enceph
viru
mycobacterium
ulceran
infect
dengu
viru
find
prompt
effort
assess
hostvector
interact
potenti
vaccin
strategi
collabor
nation
institut
health
niaid
laboratori
malaria
vector
research
recent
identifi
kda
salivari
protein
phlebotomu
papatasi
promis
vaccin
antigen
candid
leishmaniasi
discov
wildtyp
bcelldefici
mice
immun
encod
dna
vaccin
mount
efficaci
cellular
immun
respons
leishmania
major
infect
confirm
protect
due
develop
delayedtyp
hypersensit
respons
addit
altern
vaccin
strategi
genet
modifi
nonpathogen
leishmania
tarentola
parasit
secret
demonstr
l
tarentola
express
boost
desir
immun
respons
led
protect
l
major
mous
model
collabor
nation
institut
health
uniform
servic
univers
health
scienc
develop
leishmaniasi
vaccin
consist
sandfli
antigen
wellcharacter
leishmania
parasit
antigen
although
immunogen
efficaci
studi
ongo
parallel
develop
scalabl
product
process
protein
thu
allow
rapid
advanc
clinic
molecular
clone
escherichia
coli
express
platform
first
explor
sinc
protein
homolog
close
sequenc
similar
phlebotomu
duboscqi
alreadi
express
e
coli
crystal
howev
form
inclus
bodi
bacteria
thu
express
platform
use
pichia
pastori
investig
studi
develop
product
process
express
purifi
tagfre
recombin
yeast
p
pastori
includ
improv
ferment
yield
develop
scalabl
purif
scheme
conclus
studi
ferment
yield
improv
mg
per
liter
ferment
supernat
fs
mg
improv
purif
process
compris
chromatographi
step
ionexchang
chromatographi
iex
use
sp
sepharos
xl
resin
spxl
hydrophob
interact
chromatographi
hic
phenyl
sepharos
fast
flow
high
sub
resin
dynam
bind
capac
iex
hic
determin
mgml
mgml
respect
purif
process
increas
puriti
subsequ
biophys
biochem
analys
demonstr
protein
highli
pure
monomer
also
maintain
welldefin
secondari
structur
approxim
alphahelix
tertiari
structur
similar
relat
p
duboscqi
suggest
correct
fold
ph
screen
use
thermal
shift
assay
also
suggest
stabl
ph
ph
collect
data
process
character
biophys
biochem
protein
character
indic
process
thu
readi
upscal
reproduc
analysi
materi
gener
scaledup
process
assess
longterm
stabil
stabil
stress
recombin
express
vector
ppiczaa
contain
dna
sequenc
encod
ncbi
proteinid
genbank
id
first
purchas
genscript
piscataway
nj
follow
electropor
p
pastori
transform
grown
day
c
yeast
extract
pepton
dextros
agar
plate
either
mgml
zeocin
thirteen
coloni
transform
select
smallscal
ml
express
bmgybmmi
medium
induct
methanol
per
day
c
day
clone
highest
express
chosen
gener
research
seed
stock
one
millilit
seed
stock
inocul
l
bmg
buffer
minim
glycerol
medium
cultur
incub
overnight
c
constant
shake
rpm
od
reach
approxim
ml
overnight
cultur
inocul
l
steril
basal
salt
medium
contain
ml
phosphor
acid
g
caso
g
k
g
mgso
g
koh
g
glycerol
ml
trace
element
ml
dbiotin
ml
antifoam
per
liter
reach
initi
od
yeast
cell
expand
overnight
batch
mode
c
ph
glycerol
deplet
glycerol
fedbatch
phase
initi
mllh
glycerol
h
last
hour
glycerol
fedbatch
phase
temperatur
reduc
c
c
ph
increas
induct
phase
methanol
suppli
ramp
mllh
period
follow
mainten
mllh
h
methanol
suppli
increas
mllh
period
follow
mainten
mllh
end
ferment
process
total
induct
time
approxim
h
ferment
process
sampl
collect
differ
time
point
fs
harvest
centrifug
kept
c
later
process
optim
process
compar
origin
process
major
process
differ
describ
supplementari
tabl
two
liter
fs
thaw
filter
mm
filter
filter
fs
concentr
approxim
ml
buffer
exchang
mm
potassium
phosphat
buffer
ph
use
kda
cutoff
pellicon
ultracel
cassett
millipor
burlington
conduct
equal
mm
potassium
phosphat
buffer
ph
mscm
process
materi
step
denot
tangenti
flow
filtrat
tff
pool
theoret
pi
approxim
cation
exchang
chromatographi
use
spxl
resin
chosen
captur
step
determin
bind
capac
spxl
resin
tff
pool
load
onto
ml
sp
xl
column
pack
inhous
bed
height
bh
cm
id
cm
cmh
resid
time
min
breakthrough
observ
column
wash
column
volum
cv
bind
buffer
mm
potassium
phosphat
buffer
ph
step
elut
elut
buffer
elut
buffer
contain
mm
potassium
phosphat
buffer
nacl
ph
cv
appli
elut
target
protein
collect
fraction
denot
spxl
pool
gradient
elut
elut
buffer
cv
remov
host
cell
protein
hcp
impur
column
addit
polish
step
phenyl
sepharos
fast
flow
high
sub
resin
use
remov
remain
impur
two
hundr
ml
spxl
pool
retriev
mix
ammonium
sulfat
molar
ammonium
sulfat
reach
similarli
studi
bind
capac
resin
spxl
pool
ammonium
sulfat
load
onto
ml
hitrap
column
bh
cm
id
cm
ge
healthcar
flow
rate
cmh
resid
time
min
column
wash
cv
bind
buffer
mm
potassium
phosphat
buffer
ammonium
sulfat
ph
remov
loos
bound
protein
step
elut
elut
buffer
elut
buffer
contain
mm
potassium
phosphat
buffer
ph
cv
appli
elut
target
protein
collect
fraction
denot
pool
follow
second
step
elut
elut
buffer
cv
remain
impur
remov
column
collect
pool
bufferexchang
dialysi
pb
ph
buffer
need
bind
capac
establish
recoveri
step
determin
overload
column
prevent
loss
target
protein
flowthrough
analysi
inprocess
sampl
purifi
load
trisglycin
bistri
gel
subsequ
stain
coomassi
blue
silver
describ
previous
transfer
pvdf
membran
analyz
western
blot
use
inhous
mous
antisera
dilut
antip
pastori
hcp
antibodi
cygnu
cat
coomassi
blueestain
band
observ
gel
overload
extract
digest
trypsin
analyz
mass
spectrometri
yalenhlbi
proteom
center
confirm
ident
band
approxim
ml
mgml
filter
mm
anotop
filter
whatman
maidston
unit
kingdom
remov
possibl
environment
contamin
load
quadrupl
onto
clear
bottom
black
plate
aurora
biotechnolog
carlsbad
ca
sampl
measur
acquir
time
use
wyatt
plate
reader
ii
analyz
use
dynam
softwar
packag
version
wyatt
technolog
santa
barbara
ca
hplc
system
separ
modul
equip
tskgel
tosoh
bioscienc
cat
connect
guard
column
tosoh
bioscienc
cat
use
assess
aggreg
one
hundr
microlit
mgml
inject
onto
column
protein
elut
phosphat
buffer
mm
na
hpo
mm
kh
po
mm
nacl
ph
ml
min
min
gel
filtrat
standard
biorad
cat
use
control
elut
protein
monitor
nm
purifi
dilut
deioniz
water
final
concentr
approxim
mgml
analyz
circular
dichroism
cd
spectropolarimet
easton
md
faruv
cd
spectra
obtain
nm
jasco
spectrophotomet
set
nmmin
respons
time
c
obtain
cd
data
analyz
use
cdpro
softwar
compar
refer
set
use
datafit
program
contin
cdsstr
addit
sampl
heat
c
c
analyz
thermal
stabil
secondari
structur
ph
screen
thermal
shift
assay
purifi
dilut
bufferexchang
final
concentr
mgml
mm
sodium
citrat
differ
ph
valu
rang
citratephosph
buffer
ph
valu
rang
mm
sodium
borat
ph
deioniz
water
includ
neg
control
protein
thermal
shift
assay
perform
heat
sampl
c
c
monitor
fluoresc
intens
chang
use
protein
thermal
dye
kit
thermo
fisher
scientif
cat
realtim
pcr
system
analyz
softwar
optim
ferment
process
compar
default
ferment
process
analyz
use
biomass
wet
cell
weight
measur
express
level
sdspage
supplementari
fig
supplementari
tabl
major
differ
optim
process
addit
glycerol
fedbatch
phase
increas
cell
mass
induct
thu
potenti
increas
protein
yield
default
process
produc
g
biomassl
cultur
mg
fs
wherea
optim
process
produc
approxim
biomass
gl
cultur
mgl
fs
purif
inprocess
sampl
use
character
protein
puriti
tabl
bind
capac
chromatograph
step
also
determin
inform
facilit
upscal
process
low
puriti
fs
determin
densitometri
fig
tabl
like
due
heavi
contamin
host
cell
impur
degrad
fig
lane
purifi
effici
fs
first
filter
mm
filter
concentr
tff
fig
lane
reduc
volum
thu
process
time
owe
high
theoret
pi
pi
cation
exchang
chromatographi
chosen
thu
concentr
fs
buffer
exchang
use
filtrat
devic
note
diavolum
requir
reduc
sampl
conduct
level
bind
buffer
mm
potassium
phosphat
buffer
ph
protein
recov
buffer
exchang
fs
load
onto
cation
exchang
column
iex
made
spxl
resin
bind
capac
determin
mgml
spxl
flow
rate
cmh
column
bh
cm
iex
step
recov
tff
step
puriti
spxl
pool
increas
suggest
impur
host
cell
protein
remov
lane
conduct
spxl
pool
adjust
mscm
ad
ammonium
sulfat
sampl
load
onto
hic
column
contain
phenyl
sepharos
fast
flow
high
sub
remov
small
impur
kda
fig
lane
note
even
though
approxim
mg
bound
column
load
bind
tightli
column
approxim
mg
elut
wash
step
leav
mg
elut
elut
step
supplementari
fig
spxl
pool
contain
mg
load
littl
observ
wash
step
supplementari
fig
thu
bind
capac
report
remain
wash
step
per
unit
volum
resin
ml
resin
mgml
flow
rate
cmh
resid
time
min
run
puriti
product
increas
target
protein
recov
iex
step
led
high
overal
process
recoveri
rate
integr
puriti
sdspage
dl
western
blot
purifi
analyz
sdspage
studi
integr
puriti
fig
supplementari
fig
less
mg
purifi
load
onto
sdspage
gel
stain
coomassi
blue
fig
supplementari
fig
singl
band
observ
approxim
kda
trisglycin
gel
fig
kda
bistri
gel
supplementari
fig
howev
mg
load
faint
band
approxim
kda
observ
reduc
condit
light
smear
approxim
kda
nonreduc
condit
distinct
band
observ
overload
gel
supplementari
fig
recov
trypsindigest
analyz
proteom
mass
spectrometri
result
indic
kda
protein
band
contain
wherea
kda
band
contain
approxim
degrad
hcp
tabl
silverstain
sdspage
gel
similar
profil
obtain
mg
purifi
load
small
molecular
weight
impur
observ
fig
aggreg
dimer
format
observ
dl
indic
size
approxim
kda
consist
data
shown
sdspage
low
polydispers
indic
protein
monodispers
fig
assess
level
potenti
aggreg
sehplc
also
use
result
fig
indic
elut
singl
peak
min
slightli
later
retent
time
kda
protein
standard
min
wellresolv
biorad
gel
filtrat
standard
suggest
size
like
slightli
less
kda
detect
peak
elut
min
demonstr
like
aggreg
ident
puriti
sampl
also
evalu
use
western
blot
polyclon
antiserum
fig
p
pastori
hcpspecif
antibodi
fig
antisera
abl
recogn
protein
band
approxim
kda
thu
confirm
ident
theoret
molecular
weight
kda
howev
proteom
mass
spectrometr
data
indic
small
molecular
weight
impur
contain
degrad
hcp
present
recogn
either
antisera
p
pastori
hcpspecif
antibodi
suggest
impur
could
low
quantiti
requir
higher
concentr
detect
antibodi
antigen
faruv
cd
perform
investig
secondari
structur
result
indic
yeast
express
rich
alphahelic
alphahelix
betasheet
turnloop
fig
thermal
stabil
secondari
structur
evalu
heat
sampl
c
c
fig
cd
melt
curv
extract
nm
nm
nm
fig
wavelength
show
best
signal
nois
data
base
deriv
onset
structur
chang
begin
approxim
c
averag
melt
temperatur
found
c
wavelength
fig
step
elut
target
protein
buffer
screen
use
thermal
shift
assay
ph
screen
rang
ph
ph
perform
evalu
thermal
stabil
tertiari
structur
use
thermal
shift
assay
fig
base
deriv
fig
onset
temperatur
ph
could
determin
lower
c
melt
temperatur
approxim
c
suggest
may
denatur
room
temperatur
ph
ph
increas
increas
approxim
c
within
ph
rang
consist
c
c
also
observ
fig
interestingli
ph
melt
temperatur
detect
c
close
ph
wherea
c
close
higher
ph
fig
suggest
might
either
metast
state
ph
partial
lost
thermal
stabil
henc
closer
monitor
protein
tertiari
stabil
overtim
ph
need
consid
nevertheless
data
suggest
maintain
tertiari
structur
stabil
buffer
system
ph
use
previou
preclin
studi
dna
vector
encod
nonpathogen
l
tarentola
secret
use
demonstr
protect
l
major
infect
mice
suggest
promis
vaccin
candid
leishmaniasi
studi
gener
recombin
p
pastori
construct
recombin
protein
product
develop
optim
upstream
process
l
scale
develop
scalabl
downstream
process
consist
iex
hic
chromatograph
step
purifi
character
variou
biochem
biophys
assay
suitabl
ph
rang
stabil
determin
current
yeastexpress
recombin
protein
evalu
immunogen
efficaci
leishmania
infect
molecular
clone
e
coli
express
platform
first
investig
yet
unabl
produc
solubl
thu
recombin
yeast
construct
develop
optim
upstream
ferment
process
gener
optim
process
ad
glycerol
fedbatch
step
initi
deplet
glycerol
basal
salt
medium
increas
cell
densiti
induct
addit
step
increas
overal
protein
yield
respect
downstream
process
develop
owe
high
protein
pi
cation
exchang
chromatographi
logic
select
captur
step
first
conduct
fs
lower
diafiltr
reduc
process
time
kda
cutoff
cassett
test
howev
found
permeat
cassett
thu
kda
cutoff
cassett
select
howev
instead
direct
diafiltr
fs
first
concentr
reduc
process
time
requir
diafiltr
cation
exchang
chromatographi
lower
volum
buffer
requir
diafiltr
concentr
bufferexchang
fs
purifi
cm
bh
iex
column
flow
rate
cmh
use
step
elut
elut
buffer
addit
elut
step
linear
gradient
elut
buffer
appli
remov
bound
host
cell
protein
column
target
protein
recov
howev
gradient
elut
undesir
largescal
product
plan
replac
step
step
elut
elut
buffer
futur
scaleup
experi
iex
step
notic
approxim
lowmolecularweight
impur
still
present
impur
remov
hydrophob
hic
first
trial
hic
butyl
sepharos
highperform
resin
test
show
enough
bind
affin
henc
stronger
hic
resin
phenyl
sepharos
fast
flow
high
sub
chosen
use
resin
impur
reduc
addit
puriti
reach
note
typic
bh
maintain
upscal
howev
column
use
develop
phase
bh
cm
henc
scale
practic
requir
optim
futur
studi
scale
process
intend
pack
column
bh
cm
maintain
current
resid
time
min
keep
bind
capac
similar
base
bind
capac
spxl
resin
mgml
resin
mg
ml
minim
cv
resin
purifi
antigen
estim
amount
purifi
antigen
calcul
supplementari
tabl
typic
l
ferment
process
approxim
l
fs
obtain
initi
yield
mg
fs
requir
spxl
column
cv
ml
column
cv
ml
captur
purif
high
overal
recoveri
expect
collect
approxim
mg
purifi
per
litter
fs
compar
purif
process
sever
report
recombin
protein
vaccin
antigen
similar
ferment
scale
one
find
process
requir
much
less
volum
resin
addit
size
exclus
chromatographi
process
ideal
largescal
product
includ
purif
process
recombin
protein
vaccin
antigen
increas
puriti
howev
current
purif
scheme
requir
size
exclus
chromatographi
step
improv
puriti
chosen
purif
step
scalabl
except
dialysi
use
exchang
appropri
buffer
due
small
volum
develop
phase
futur
upscal
plan
replac
dialysi
step
diafiltr
use
kda
cassett
respect
protein
character
sever
biophys
biochem
assay
perform
studi
characterist
protein
well
known
recombin
protein
express
yeast
potenti
heavili
nglycosyl
nglycosyl
assess
screen
presenc
consensu
sequenc
nglycosyl
asnxxxserthrci
xxx
amino
acid
except
prolin
conduct
sequenc
supplementari
fig
asn
residu
follow
howev
amino
acid
thu
like
glycosyl
sdspage
gel
mass
spectrometri
also
indic
absenc
nglycan
sensit
specif
assay
also
appli
studi
purityimpur
includ
silverstain
sdspage
western
blot
antip
pastori
hcp
western
blot
result
suggest
trace
amount
hcp
productderiv
impur
degrad
present
purifi
sampl
moreov
detect
aggreg
found
also
support
dl
sehplc
inde
low
bind
affin
hic
column
explain
protein
like
highli
hydrophil
addit
compar
sequenc
crystal
structur
exclud
signal
peptid
predict
cystein
residu
form
disulfid
bridg
thu
free
cystein
residu
present
form
intermolecular
disulfid
bridg
find
suggest
low
tendenc
aggreg
desir
properti
longterm
stabil
secondari
structur
analyz
faruv
cd
indic
highli
alphahel
protein
alphahelix
betasheet
result
consist
secondari
structur
homolog
pdb
id
helix
valid
assay
final
ph
screen
use
thermal
shift
assay
conduct
determin
proper
ph
system
maintain
stabil
note
onset
temperatur
melt
temperatur
remain
constant
ph
howev
lower
melt
temperatur
observ
ph
suggest
instabl
indic
buffer
formul
ph
lower
avoid
conclus
product
process
recombin
leishmaniasi
vaccin
antigen
candid
develop
upstream
product
process
optim
gener
approxim
g
per
liter
fs
tagfre
recombin
protein
abl
purifi
purif
process
involv
ionexchang
column
hydrophob
interact
column
bind
capac
chromatograph
step
determin
even
though
minor
adjust
requir
process
suitabl
upscal
studi
process
recoveri
process
reproduc
character
show
protein
highli
pure
welldefin
structur
futur
studi
focus
understand
longterm
stabil
stabil
differ
stress
piec
inform
along
ongo
preclin
studi
inform
whether
path
forward
manufactur
econom
vaccin
neglect
tropic
diseas
